Ali Bazargan

Fitzroy, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Favezelimab plus pembrolizumab for anti-PD-1-refractory classic Hodgkin lymphoma: an open-label phase 1/2 study.

Favezelimab plus pembrolizumab for anti-PD-1-refractory classic Hodgkin lymphoma: an open-label phase 1/2 study.

Journal: Blood neoplasia
Published: September 26, 2025

Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.

Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.

Journal: Leukemia & lymphoma
Published: October 07, 2020

Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy.

Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy.

Journal: Leukemia & lymphoma
Published: September 28, 2020

Pembrolizumab associated sarcoid-like lymphadenopathy mimicking progressive disease in Hodgkin lymphoma.

Pembrolizumab associated sarcoid-like lymphadenopathy mimicking progressive disease in Hodgkin lymphoma.

Journal: Pathology
Published: June 14, 2020

Acquired Pure Red Cell Aplasia Associated with Chronic Myelomonocytic Leukemia: Too Many of One, Not Enough of the Other.

Acquired Pure Red Cell Aplasia Associated with Chronic Myelomonocytic Leukemia: Too Many of One, Not Enough of the Other.

Journal: Case reports in oncology
Published: May 19, 2020

Addition of low dose acetazolamide as an adjunct in patients undergoing high dose methotrexate is safe and beneficial.

Addition of low dose acetazolamide as an adjunct in patients undergoing high dose methotrexate is safe and beneficial.

Journal: Internal medicine journal
Published: November 22, 2018

The positive effect of deferasirox on erythropoiesis in a patient with a dual diagnosis of myelofibrosis and diffuse large B-cell lymphoma.

The positive effect of deferasirox on erythropoiesis in a patient with a dual diagnosis of myelofibrosis and diffuse large B-cell lymphoma.

Journal: Leukemia & lymphoma
Published: March 24, 2017

Intense focal pituitary FDG uptake due to intravascular large B-cell lymphoma in pyrexia of unknown origin.

Intense focal pituitary FDG uptake due to intravascular large B-cell lymphoma in pyrexia of unknown origin.

Journal: American journal of hematology
Published: June 30, 2016

Response.

Response.

Journal: Chest
Published: December 02, 2015

Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy.

Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy.

Journal: Leukemia & lymphoma
Published: October 15, 2015

Use of Lenalidomide in 5q-Myelodysplastic Syndrome Provides Novel Treatment Prospects in Management of Pulmonary Sarcoidosis.

Use of Lenalidomide in 5q-Myelodysplastic Syndrome Provides Novel Treatment Prospects in Management of Pulmonary Sarcoidosis.

Journal: Chest
Published: August 05, 2015

Methotrexate-associated EBV-positive CD20-negative diffuse large B-cell lymphoma localized to skin presenting as multiple chronic lower leg ulcers.

Methotrexate-associated EBV-positive CD20-negative diffuse large B-cell lymphoma localized to skin presenting as multiple chronic lower leg ulcers.

Journal: Leukemia & lymphoma
Published: June 26, 2015
Showing 1-12 of 20

Last Updated: 09/26/2026